Activation of caspase-3 is also supported by studies demonstrating cellular modifications including neuronal cell death within the brain tissue of TBI patients [114], and has been considered a key feature of neurodegenerative diseases [115]. The gene discussed is CASP3; the disease is neurodegenerative disease.